A direct effect of progesterone on Brca1-associated breast cancer was demonstrated in studies on Brca1;p53 deficient mice; administration of the progesterone antagonist mifepristone markedly blocked tumour development in this mouse model [64]. The gene discussed is TP53; the disease is breast cancer.